Evaluating the effect of early versus late ARV regimen change if failure on an initial regimen: results from the AIDS clinical trials group study A5095

DOI10.1080/01621459.2011.646932MaRDI QIDQ4916488zbMATH OpenOpenAlexWikidataFDO

Authors Li Li, Joseph J. jun. Eron, Heather Ribaudo, Roy M. Gulick, Brent A. Johnson

Publication date 22 April 2013

Published in Journal of the American Statistical Association (Search for Journal in Brave)

Full work available at URL http://europepmc.org/articles/pmc3545451

zbMATH Keywords

causal inferencemissing datadouble robustnessRubin causal modellongitudinal data analysissemiparametric efficient estimation

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)

Recommendations

• Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching times
• Viral suppression in HIV studies: combining times to suppression and rebound
• Estimating causal treatment effects from longitudinal HIV natural history studies using marginal structural models
• Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients
• Doubly robust estimation of optimal treatment regimes for survival data -- with application to an HIV/AIDS study

Cites work

• A Distributional Approach for Causal Inference Using Propensity Scores
• A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect
• Comment: Performance of double-robust estimators when ``inverse probability weights are highly variable
• Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials
• Exact Confidence Intervals Following a Group Sequential Test
• Marginal Mean Models for Dynamic Regimes
• Optimal Estimator for the Survival Distribution and Related Quantities for Treatment Policies in Two‐Stage Randomization Designs in Clinical Trials
• Semiparametric theory and missing data.
• Some results on generalized difference estimation and generalized regression estimation for finite populations
• The central role of the propensity score in observational studies for causal effects

Cited in

(1)

• Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching times

This page was built for publication: Evaluating the effect of early versus late ARV regimen change if failure on an initial regimen: results from the AIDS clinical trials group study A5095

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4916488)